Conference Material
|
Slide Presentation
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
Berry C,
Motta I,
Kazounis E,
Fielding K,
Dodd M,
Nyang'wa BT,
Moodliar R
View HTML
View PDF
Share
Download
Download
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
No abstract available
Countries
Belarus
South Africa
Uzbekistan
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
Languages
English
DOI
10.57740/v9ye-0032
Published Date
11 May 2022
Conference
MSF Scientific Days International 2022
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial | Conference Material / Slide Presentation | MSF Science Portal
